Zoetis Inc. Files 8-K Report
Ticker: ZTS · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1555280
| Field | Detail |
|---|---|
| Company | Zoetis Inc. (ZTS) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $0.500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, financial-statements, filing
Related Tickers: ZTS
TL;DR
Zoetis filed a routine 8-K on Feb 6, 2025, no major news.
AI Summary
On February 6, 2025, Zoetis Inc. filed an 8-K report to disclose information under Regulation FD and to file financial statements and exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.
Why It Matters
This filing serves as a standard disclosure for Zoetis Inc., informing the public about regulatory compliance and the submission of financial documents.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information that would typically impact risk.
Key Players & Entities
- Zoetis Inc. (company) — Registrant
- February 6, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing by Zoetis Inc.?
The primary purpose of this 8-K filing is to report under Regulation FD and to file financial statements and exhibits.
What is the exact date of the earliest event reported in this filing?
The earliest event reported in this filing is dated February 6, 2025.
What is Zoetis Inc.'s principal executive office address?
Zoetis Inc.'s principal executive office is located at 10 Sylvan Way, Parsippany, New Jersey 07054.
What is Zoetis Inc.'s telephone number?
Zoetis Inc.'s telephone number is (973) 822-7000.
What is the SIC code for Zoetis Inc.?
The Standard Industrial Classification (SIC) code for Zoetis Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-02-06 16:20:12
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share ZTS New York Stock Exchange
- $0.500 — 025, the Company declared a dividend of $0.500 per share for the second quarter of 202
Filing Documents
- zts-20250206.htm (8-K) — 27KB
- exhibit9912q2025dividendpr.htm (EX-99.1) — 12KB
- image_0a.jpg (GRAPHIC) — 16KB
- 0001555280-25-000022.txt ( ) — 186KB
- zts-20250206.xsd (EX-101.SCH) — 2KB
- zts-20250206_lab.xml (EX-101.LAB) — 22KB
- zts-20250206_pre.xml (EX-101.PRE) — 13KB
- zts-20250206_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On February 6, 2025, the Company declared a dividend of $0.500 per share for the second quarter of 2025. The dividend will be paid on June 3, 2025, to all holders of record of the Company's common stock as of the close of business on April 21, 2025. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued on February 6, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZOETIS INC. Dated: February 6, 2025 By: /s/ Roxanne Lagano Roxanne Lagano Executive Vice President, General Counsel and Corporate Secretary